NMCAX
Price
$17.06
Change
+$0.03 (+0.18%)
Updated
Jun 22 closing price
Net Assets
593.73M
TRQZX
Price
$99.69
Change
-$0.91 (-0.90%)
Updated
Jun 23 closing price
Net Assets
22.46B
Interact to see
Advertisement

NMCAX vs TRQZX

NMCAX vs TRQZX Comparison Chart in %
View a ticker or compare two or three
VS
NMCAX vs. TRQZX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NMCAX is a Hold and TRQZX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TRQZX has more cash in the bank: 22.5B vs. NMCAX (594M). TRQZX pays higher dividends than NMCAX: TRQZX (0.72) vs NMCAX (0.00). NMCAX was incepted earlier than TRQZX: NMCAX (28 years) vs TRQZX (6 years). NMCAX (1.19) is less costly to investors than TRQZX (0.61). NMCAX is a more actively managed with annual turnover of: 87.00 vs. TRQZX (31.50). TRQZX has a lower initial minimum investment than NMCAX: TRQZX (0) vs NMCAX (1000). TRQZX annual gain was more profitable for investors over the last year : 0.80 vs. NMCAX (-8.39). TRQZX return over 5 years is better than : -17.08 vs. NMCAX (-31.58).
NMCAXTRQZXNMCAX / TRQZX
Total Expense Ratio1.190.00-
Annual Report Gross Expense Ratio1.190.61195%
Fund Existence28 years6 years-
Gain YTD8.8182.319380%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets594M22.5B3%
Annual Yield % from dividends0.000.72-
Returns for 1 year-8.390.80-1,053%
Returns for 3 years4.104.8285%
Returns for 5 years-31.58-17.08185%
Returns for 10 years-18.56N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTMKX54.91N/A
N/A
Fidelity Advisor Focused Em Mkts M
NGDLX31.01N/A
N/A
Neuberger Large Cap Growth Inst
RRRZX23.95N/A
N/A
DWS RREEF Real Estate Securities R6
MOJAX19.37N/A
N/A
DF Tactical Momentum Fund A
HDIVX20.91-0.39
-1.83%
Janus Henderson International Div I